Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Only anti-androgenic drugs likely halt AGA progression.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.